Viewpoint: Elective, unproven IV therapies create ‘perfect storm of risks’

3-10-2019 bellacures
Image credit: Bellacures

We don’t have to look very far these days to find wellness facilities touting this or that intravenous (IV) infusion for “detoxification” and “revitalization.” Albeit vitamin concoctions to anti-aging “young blood” transfusions, people seem to be willing to try and sell anything no matter the cost or potential for harm. And without full disclosure of components.

To a physician, the notion of placing an invasive intravenous line, in environments that may lack rigorous sterile conditions and create a source for infection, in an otherwise healthy person to administer an unproven, untested “remedy” in a spa suite routinely untethered to a tertiary care center lacking in stocking proper resuscitative measures is baffling.

Related article:  Your blood type may influence your vulnerability to stomach flu

Missouri man recently got sick during an elective “vitamin” infusion at a spa in Kansas City and died several days later.

In healthcare, less is often more since every action is often met with an equal and opposite reaction. Adding risk factors which is what needle insertion via elective IV placement alone achieves is not advisable. Tacking onto that unknown ingredients propelled directly into the bloodstream and a perfect storm of risks outweighing benefits is manifested. As the fees blossom, so should one’s skepticism.

Read full, original post: The Real Deal With Elective IV ‘Therapy’

Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
Infographic: The evolutionary history of the COVID-19 coronavirus

Infographic: The evolutionary history of the COVID-19 coronavirus

Reuters analysed over 185,000 genome samples from the Global Initiative on Sharing All influenza Data (GISAID), the largest database of ...

Environmental Working Group: EWG challenges safety of GMOs, food pesticide residues

Known by some as the "Environmental Worrying Group," EWG lobbies ...
m hansen

Michael Hansen: Architect of Consumers Union ongoing anti-GMO campaign

Michael K. Hansen (born 1956) is thought by critics to be ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend